Andere Sprachen Nuformix plc

Aktien

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:06 10.05.2024			% 5 Tage	% 1. Jan.
0,185 ^GBX	0,00 %		+5,71 %	-43,08 %

01.03.	Nuformix kündigt Zeichnung an, um GBP150.000 aufzubringen	AN
15.01.	Nuformix plc meldet Ergebnis für die achtzehn Monate bis zum 30. September 2023	CI

Nuformix announces subscription to raise GBP150,000	01.03.
Nuformix plc Reports Earnings Results for the Eighteen Months Ended September 30, 2023	15.01.
Nuformix narrows annual loss as develops drug assets	03.01.
Earnings Flash (NFX.L) NUFORMIX Reports FY23 Loss GBX-0.12	03.01.
Nuformix plc Reports Earnings Results for the Half Year Ended September 30, 2023	03.01.
Nuformix gets patent in Japan for pulmonary fibrosis treatment NXP002	23.10.23
Nuformix Receives Japanese Patent for Pulmonary Fibrosis Treatment; Shares Surge	23.10.23
Nuformix plc Announces Notice of Allowance of NXP002 Patent in Japan	23.10.23
Nuformix to fund its unlicensed programs with NXP001 windfall	05.10.23
Nuformix Updates Oxilio Agreement for NXP001	18.09.23
Nuformix to receive milestone payments from Oxilio pact	18.09.23
Nuformix plc Receives New NXP001 Development Milestone Payments in Updated Oxilio Agreement	18.09.23
Nuformix loss narrows; near-term goal to focus on NXP002 asset	22.05.23
Earnings Flash (NFX.L) NUFORMIX Posts FY23 EPS GBX0.11	22.05.23
Earnings Flash (NFX.L) NUFORMIX Posts Fiscal H1 EPS GBX0.11	22.05.23
Nuformix plc Reports Earnings Results for the Full Year Ended March 31, 2023	22.05.23
Nuformix says NXP002 shows anti-inflammatory effect	18.05.23
Nuformix to Launch Partnering Process for Inhaled Lung Disease Drug	18.05.23
Nuformix plc Announces Update Regarding the NXP002 Programme	18.05.23
FTSE 100 Inches Up as Market Awaits Key Inflation, Earnings Figures	17.04.23

Keine Ergebnisse zu dieser Suche